In patients with asthma, the IgE-mediated activation of these cells following allergen exposure induces release of vasoactive and smooth muscle-constricting mediators, that trigger acute airflow obstruction, as well as the production of bioactive lipids, cytokines, and chemokines (Bradding and Arthur, 2016). Here, IGHE is linked to asthma.